 Children suffering dystrophic epidermolysis bullosa DEB, a serious genetic disease, are affectionately called butterfly children, depicting their fragile, recurrent blistering skin with chronic open wounds. Currently, there are three potential DEB treatments that have completed, or are near the end of the developmentalregulatory process, namely AMYTs Filsuvez, KRYSs B-VEC and ABEOs EB-101. 